Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NADOLOL vs NAFCILLIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NADOLOL vs NAFCILLIN: Safety Overview

Metric NADOLOL NAFCILLIN
Total FAERS Reports 1,878 215
Deaths Reported 141 18
Death Rate 7.5% 8.4%
Hospitalizations 607 98
Average Patient Age 57.0 yrs 50.7 yrs
% Female Patients 84.2% 50.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer American Health Packaging Eugia US LLC
Route ORAL INTRAVENOUS
Marketing Status Discontinued Discontinued